Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma

被引：0
|
作者：
Brian A. Boone
Nathan Bahary
Amer H Zureikat
A. James Moser
Daniel P Normolle
Wen-Chi Wu
Aatur D. Singhi
Phillip Bao
David L Bartlett
Lance A Liotta
Virginia Espina
Patricia Loughran
Michael T. Lotze
Herbert J. Zeh
机构：
[1] University of Pittsburgh,Department of Surgery
[2] University of Pittsburgh,Department of Medicine
[3] University of Pittsburgh,Department of Pathology
[4] University of Pittsburgh,Department of Biostatistics
[5] George Mason University,Center for Applied Proteomics and Molecular Medicine
[6] Harvard Medical School,Institute for Hepatobiliary and Pancreatic Surgery, Beth Israel Deaconess Medical Center
来源：
Annals of Surgical Oncology | 2015年 / 22卷
关键词：
Gemcitabine; Pancreatic Ductal Adenocarcinoma; Stereotactic Body Radiotherapy; Autophagy Inhibition; Pancreatic Carcinogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4402 / 4410
页数：8
相关论文
共 50 条
  • [1] Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
    Boone, Brian A.
    Bahary, Nathan
    Zureikat, Amer H.
    Moser, A. James
    Normolle, Daniel P.
    Wu, Wen-Chi
    Singhi, Aatur D.
    Bao, Phillip
    Bartlett, David L.
    Liotta, Lance A.
    Espina, Virginia
    Loughran, Patricia
    Lotze, Michael T.
    Zeh, Herbert J., III
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (13) : 4402 - 4410
  • [2] Phase I/II trial of autophagy inhibition in combination with neoadjuvant gemcitabine in patients with high-risk pancreatic adenocarcinoma: Safety, clinical response, and correlative studies
    Lotze, Michael T.
    Boone, Brian A.
    Zureikat, Amer H.
    Bahary, Nathan
    Lehman, David
    Liotta, Lance A.
    Zeh, Herbert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [3] Spiral CT and the pre-operative assessment of pancreatic adenocarcinoma
    Coley, SC
    Strickland, NH
    Walker, JD
    Williamson, RCN
    CLINICAL RADIOLOGY, 1997, 52 (01) : 24 - 30
  • [4] Phase I/II Trial of Autophagy Inhibition in Combination with Neoadjuvant Gemcitabine in High-risk Pancreatic Adenocarcinoma: Safety, Clinical Response, and Correlative Studies
    Boone, B. A.
    Lotze, M. T.
    Zureikat, A. H.
    Bahary, N.
    Singhi, A. D.
    Bartlett, D. L.
    Espina, V.
    Liotta, L. A.
    Zeh, H. J.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S7 - S7
  • [5] Feasibility of pre-operative chemoradiotherapy with gemcitabine to treat pancreatic cancer in patients with impaired renal function
    Tomimaru, Yoshito
    Eguchi, Hidetoshi
    Satoh, Taroh
    Tomokuni, Akira
    Asaoka, Tadafumi
    Wada, Hiroshi
    Marubashi, Shigeru
    Ogawa, Kazuhiko
    Takehara, Tetsuo
    Mori, Masaki
    Doki, Yuichiro
    Nagano, Hiroaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) : 343 - 348
  • [6] The Natural History of Pre-Operative Indeterminate Pulmonary Nodules in Patients with Resectable Pancreatic Adenocarcinoma
    Nguyen, D. C.
    Chang, S.
    Gongfu, Z.
    Wang-Gillam, A.
    Linehan, D. C.
    Hawkins, W. G.
    Strasberg, S. M.
    Menias, C.
    Raptis, C.
    Fields, R. C.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S125 - S126
  • [7] Pre-Operative Chemoradiation Therapy for Patients With Pancreatic Cancer
    Satoi, S.
    Yanagimoto, H.
    Toyokawa, H.
    Yui, R.
    Yamamoto, T.
    Hirooka, S.
    Yamaki, S.
    Takahashi, K.
    Matsui, Y.
    Kwon, A. H.
    PANCREAS, 2009, 38 (08) : 1044 - 1044
  • [8] Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation
    Gerard M. Healy
    Emmanuel Salinas-Miranda
    Rahi Jain
    Xin Dong
    Dominik Deniffel
    Ayelet Borgida
    Ali Hosni
    David T. Ryan
    Nwabundo Njeze
    Anne McGuire
    Kevin C. Conlon
    Jonathan D. Dodd
    Edmund Ronan Ryan
    Robert C. Grant
    Steven Gallinger
    Masoom A. Haider
    European Radiology, 2022, 32 : 2492 - 2505
  • [9] Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation
    Healy, Gerard M.
    Salinas-Miranda, Emmanuel
    Jain, Rahi
    Dong, Xin
    Deniffel, Dominik
    Borgida, Ayelet
    Hosni, Ali
    Ryan, David T.
    Njeze, Nwabundo
    McGuire, Anne
    Conlon, Kevin C.
    Dodd, Jonathan D.
    Ryan, Edmund Ronan
    Grant, Robert C.
    Gallinger, Steven
    Haider, Masoom A.
    EUROPEAN RADIOLOGY, 2022, 32 (04) : 2492 - 2505
  • [10] Identification of Risk Factors for Venous Thromboembolism in Pancreatic Ductal Adenocarcinoma Patients Undergoing Pre-Operative Chemotherapy
    Boone, B. A.
    Rieser, C.
    Hamad, A.
    Zenati, M. S.
    Zureikat, A.
    Hogg, M.
    Neal, M. D.
    Zeh, H.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S128 - S128
12345